A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Conditions
- Non-small Cell Lung Cancer
Interventions
- DRUG: BL-B01D1
- DRUG: Osimertinib Mesylate Tablets
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Collaborators